• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型多发性内分泌腺瘤病伴难治性低血糖及肺和肝转移:1例报告

Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: a case report.

作者信息

Wang Yong, Zhang Hui

机构信息

Department of Radiology, the First Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Department of Radiology, Hebei General Hospital, Shijiazhuang 050000, China.

出版信息

J Int Med Res. 2021 Jan;49(1):300060520961682. doi: 10.1177/0300060520961682.

DOI:10.1177/0300060520961682
PMID:33435778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809309/
Abstract

BACKGROUND

Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant genetic disease. MEN1 with multiple endocrine adenomatosis complicated by multiple endocrine tumors is often misdiagnosed or missed. Herein, we describe the first reported case of refractory hypoglycemia and liver and lung metastases in a patient with MEN1.Case presentation: A 40-year-old man presented with a 3-month history of intermittent palpitations, fatigue, and sweating. The patient had a history of prolactinoma resection and refractory hypoglycemia 2 years earlier. Analyses of blood samples showed a decrease in random and fasting blood glucose and an increase in prolactin (PRL). Computed tomography (CT) and magnetic resonance imaging scans revealed two substantial masses in the pancreas and large masses in the liver and lung. Positron emission tomography-CT images showed hypermetabolic masses in the pancreatic body and tail. The liver and lung lesions were also hypermetabolic. The pancreatic lesion was surgically removed, and pathology confirmed that the mass was MEN1. The liver and lung masses were confirmed as metastatic tumors.

CONCLUSION

If clinicians better understand MEN1, they can obtain a detailed patient and family history during the initial visit, allowing earlier diagnosis and intervention and improved prognosis.

摘要

背景

1型多发性内分泌腺瘤病(MEN1)是一种罕见的常染色体显性遗传病。MEN1合并多发性内分泌腺病并伴有多种内分泌肿瘤时,常被误诊或漏诊。在此,我们报告首例MEN1患者出现难治性低血糖及肝肺转移的病例。

病例介绍

一名40岁男性,有3个月间歇性心悸、乏力和出汗病史。该患者2年前有催乳素瘤切除及难治性低血糖病史。血液样本分析显示随机血糖和空腹血糖降低,催乳素(PRL)升高。计算机断层扫描(CT)和磁共振成像扫描显示胰腺有两个实质性肿块,肝脏和肺部有较大肿块。正电子发射断层扫描-CT图像显示胰体和胰尾有高代谢肿块。肝脏和肺部病变也呈高代谢。胰腺病变经手术切除,病理证实肿块为MEN1。肝脏和肺部肿块被确认为转移瘤。

结论

如果临床医生对MEN1有更好的了解,他们可以在初次就诊时获取详细的患者和家族病史,从而实现早期诊断和干预,改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f0e/7809309/132d9ce8e4c2/10.1177_0300060520961682-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f0e/7809309/132d9ce8e4c2/10.1177_0300060520961682-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f0e/7809309/132d9ce8e4c2/10.1177_0300060520961682-fig1.jpg

相似文献

1
Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: a case report.1型多发性内分泌腺瘤病伴难治性低血糖及肺和肝转移:1例报告
J Int Med Res. 2021 Jan;49(1):300060520961682. doi: 10.1177/0300060520961682.
2
68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.68Ga-DOTATATE PET/CT 成像在 MEN1 伴内源性高胰岛素血症低血糖症患者胰岛素瘤中的应用:病例报告。
Medicine (Baltimore). 2022 Aug 26;101(34):e30252. doi: 10.1097/MD.0000000000030252.
3
[A Patient with Multiple Endocrine Neoplasia Type1(MEN1)Presenting with Hypoglycemic Attacks].[1例以低血糖发作为表现的多发性内分泌腺瘤1型(MEN1)患者]
No Shinkei Geka. 2015 May;43(5):451-6. doi: 10.11477/mf.1436203045.
4
[Multiple Endocrine Neoplasia Type 1(MEN1)Presenting with Hypoglycemic Attacks - A Case Report].[以低血糖发作表现的1型多发性内分泌腺瘤病(MEN1)——病例报告]
Gan To Kagaku Ryoho. 2016 Nov;43(12):2196-2198.
5
Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1.一名患有1型多发性内分泌腺瘤病的中国患者,其胰腺周围区域存在无功能胰腺内分泌肿瘤。
J Int Med Res. 2018 Feb;46(2):908-915. doi: 10.1177/0300060517728653. Epub 2017 Sep 14.
6
Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.由于胰岛素瘤伴 AIP 同时存在,导致 MEN1 病例的诊断延迟很长时间:病例报告和文献复习。
BMC Endocr Disord. 2022 Apr 21;22(1):108. doi: 10.1186/s12902-022-01022-6.
7
Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.18F-氟脱氧葡萄糖正电子发射断层显像在多内分泌腺瘤1型胰腺神经内分泌肿瘤风险分层中的应用
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1926-1933. doi: 10.1210/jc.2016-3865.
8
A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas.1例1型多发性内分泌肿瘤伴食管狭窄经内镜球囊扩张、局部类固醇注射联合胃泌素瘤手术切除成功治疗。
BMC Gastroenterol. 2017 Mar 7;17(1):37. doi: 10.1186/s12876-017-0597-6.
9
Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.(68)Ga-DOTA-TOC PET/CT用于检测MEN1患者十二指肠胰腺神经内分泌肿瘤的评估
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1258-66. doi: 10.1007/s00259-016-3319-3. Epub 2016 Jan 28.
10
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).(68)镓- DOTATATE正电子发射断层显像/计算机断层扫描(PET/CT)在1型多发性内分泌腺瘤病(MEN1)患者中的作用
Endocrine. 2016 Jun;52(3):488-94. doi: 10.1007/s12020-015-0702-y. Epub 2015 Aug 5.

本文引用的文献

1
CO-EXISTENCE OF PRIMARY HYPERPARATHYROIDISM DUE TO MULTIPLE ENDOCRINE NEOPLASIA 1 IN A HYPERCALCEMIC PATIENT WITH GRAVES DISEASE.一名患有格雷夫斯病的高钙血症患者同时存在由多发性内分泌肿瘤1型引起的原发性甲状旁腺功能亢进。
AACE Clin Case Rep. 2019 Jan 30;5(1):e13-e15. doi: 10.4158/ACCR-2018-0217. eCollection 2019 Jan-Feb.
2
Multiple endocrine neoplasia: an update.多发性内分泌肿瘤:更新。
Intern Med J. 2019 Aug;49(8):954-961. doi: 10.1111/imj.14394.
3
Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1.
儿童和青年期多发性内分泌腺瘤病 1 型的表现和结局。
Clin Endocrinol (Oxf). 2019 Nov;91(5):633-638. doi: 10.1111/cen.14067. Epub 2019 Aug 14.
4
Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?磁共振成像或内镜超声检查用于多发性内分泌肿瘤 1 型患者胰腺神经内分泌肿瘤的检测和监测?
Horm Metab Res. 2019 Sep;51(9):580-585. doi: 10.1055/a-0931-7005. Epub 2019 Jul 11.
5
Granular Cell Pituitary Tumor in a Patient with Multiple Endocrine Neoplasia-1.1型多发性内分泌腺瘤病患者的颗粒细胞垂体瘤
Cureus. 2019 Apr 25;11(4):e4541. doi: 10.7759/cureus.4541.
6
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).神经内分泌肿瘤异质性给 2010 年世界卫生组织分类带来不确定性:来自西班牙肿瘤登记处(R-GETNE)的真实世界数据。
Oncologist. 2018 Apr;23(4):422-432. doi: 10.1634/theoncologist.2017-0364. Epub 2018 Jan 12.
7
Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story.1型多发性内分泌腺瘤综合征的基因检测:一个不断发展的故事。
World J Exp Med. 2015 May 20;5(2):124-9. doi: 10.5493/wjem.v5.i2.124.
8
Care for patients with multiple endocrine neoplasia type 1: the current evidence base.照顾多发性内分泌肿瘤 1 型患者:当前的证据基础。
Fam Cancer. 2011 Mar;10(1):157-71. doi: 10.1007/s10689-010-9398-6.
9
Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.1型多发性内分泌肿瘤(MEN1):其临床表现及基因筛查对临床结局的影响。
Clin Endocrinol (Oxf). 2009 Apr;70(4):575-81. doi: 10.1111/j.1365-2265.2008.03324.x. Epub 2008 Jun 25.